Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases

HPB

Volumn 11, Issue 7, 2009, Pages 592-599

  Reddy, Srinevas K ^a   Kattan, Michael W ^b   Yu, Changhong ^b   Ceppa, Eugene P ^a   De La Fuente, Sebastian G ^a   Fong, Yuman ^c   Clary, Bryan M ^a   White, Rebekah R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Colorectal liver metastases; Nomogram

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PROBABILITY; PROGNOSIS; TREATMENT DURATION; TUMOR VOLUME;

EID: 73349129982     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00106.x     Document Type: Article

References (46)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318.
2. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W et al. (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703-710.
3. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 77:1254-1262.
4. Cady B, Stone MD, McDermott WV Jr, Jenkins RL, Bothe A Jr, Lavin PT et al. (1992) Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 127:561-568.
5. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC et al. (1999) Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 189:291-299.
6. Konopke R, Kersting S, Distler M, Dietrich J, Gastmeier J, Heller A et al. (2009) Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 29:89-102.
7. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D et al. (2007) Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246:806-814.
8. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati P. (2001) Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg 25:638-644.
9. Rees M, Tekkis PP, Welsh FKS, O'Rourke T, John TG. (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:125-135.
10. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM et al. (2007) Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 246:183-191.
11. Arru M, Aldrighetti L, Castoldi R, Di Palo S, Orsenigo E, Stella M et al. (2008) Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93-103.
12. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ. (2004) The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 139:1168-1172.
13. Chen YY, Perera DS, Yan TD, Schmidt LM, Morris DL. (2006) Applying Fong's CRS liver score in patients with colorectal liver metastases treated by cryotherapy. Asian J Surg 29:238-241.
14. Mala T, Bøhler G, Mathisen ∅, Bergan A, Søreide O. (2002) Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26:1348-1353.
15. Tan MCB, Castaldo ET, Gao F, Chari RS, Linehan DC, Wright JK et al. (2008) A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by Postitron Emmision Tomography with [18F]Fluoro-2-Deoxy-Glucose: the role of primary tumor variables. J Am Coll Surg 206:857-869.
16. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M et al. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575-4580.
17. Kattan MW, Gönen M, Jarnagin WR, DeMatteo R, D'Angelica M, Weiser M et al. (2008) A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer. Ann Surg 247:282-287.
18. Kanemitsu Y, Kato T. (2008) Prognostic models for predicting death after hepatectomy in individuals with hepatic metastases from colorectal cancer. World J Surg 32:1097-1107.
19. Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH. (2005) Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data. J Clin Oncol 23:175-183.
20. Kattan MW, Vickers AJ, Yu C, Bianco FJ, Cronin AM, Eastham JA et al. (2009) Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer. Cancer 115:1005-1010.
21. Lagarde SM, Reitsma JB, Ten Kate FJ, Busch OR, Obertop H, Zwinderman AH et al. (2008) Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction. Ann Surg 248:1006-1013.
22. Cho CS, Gonen M, Shia J, Kattan MW, Klimstra DS, Jarnagin WR et al. (2008) A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma. J Am Coll Surg 206:281-291.
23. Motzer RJ, Bukowski RM, Figlin RA, Hutson TE, Michaelson MD, Kim ST et al. (2008) Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma. Cancer 113:1552-1558.
24. Brennan MF, Kattan MW, Klimstra D, Colon K. (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293-298.
25. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007-1016.
26. Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D et al. (2008) Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 26:4906-4911.
27. Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero D et al. (2008) Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol 16:1809-1819.
28. Parks R, Gonen M, Kemeny N, Jarnagin W, D'Angelica M, DeMatteo R et al. (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204:753-761.
29. Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Ragué J et al. (2007) Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum 50:478-488.
30. Reddy SK, Broadwater G, Niedzwiecki D, Barbas AS, Hurwitz HI, Bendell JC et al. (2009) Multiagent chemotherapy for isolated colorectal liver metastases: a single-centered retrospective study. J Gastrointest Surg 13:74-84.
31. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M et al. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25:4575-4580.
32. Viganò L, Ferrero A, Lo Tesoriere R, Capussotti L. (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15:2458-2464.
33. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al. (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715-722.
34. Kornprat P, Jarnagin WR, Gonen M, DeMatteo RP, Fong Y, Blumgart LH et al. (2007) Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151-1160.
35. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B et al. (2004) Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 240:1052-1061.
36. Blazer DG, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ et al. (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of colorectal liver metastases. J Clin Oncol 25:5344-5351.
37. Pawlik TM, Assumpcao L, Vossen JA, Buijs M, Gleisner AL, Schulick R et al. (2009) Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases. Ann Surg Oncol 16:371-378.
38. Huguet EL, Old S, Praseedom RK, Balan KK, Gibbs P, Jamieson NV. (2007) F18-FDG-PET evaluation of patients for resection of colorectal liver metastases. Hepatogastroenterology 54:1667-1671.
39. Sorensen M, Mortensen FV, Hoyer M, Vilstrup H, Keiding S. (2007) FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study. Scand J Surg 96:209-213.
40. Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y et al. (2007) The impact of 18F-FDG PET/CT in patients with liver metastases. Eur J Nucl Med Imaging 34:1906-1914.
41. Riedl CC, Akhurst T, Larson S, Stanziale SF, Tuorto S, Bhargava A et al. (2007) 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. J Nucl Med 48:771-775.
42. Joyce DL, Wahl RL, Patel PV, Schulick RD, Gearhart SL, Choti MA. (2006) Preoperative positron emission tomography to evaluate potentially resectable hepatic colorectal metastases. Arch Surg 141:1220-1226.
43. Are C, Gonen M, Zazzali K, DeMatteo RP, Jarnagin WR, Fong Y et al. (2007) The impact of margins on outcome after hepatic resection of colorectal metastases. Ann Surg 246:295-300.
44. Wakai T, Shirai Y, Sakata J, Valera VA, Korita PV. (2008) Akazawa K, et al. Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastases. Ann Surg Oncol 15:2472-2481.
45. Konopke R, Kersting S, Makowiec F, Gabmann P, Kuhlisch E, Senninger N et al. (2008) Resection of colorectal liver metastases: is a resection margin of 3 mm enough? World J Surg 32:2047-2056.
46. Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B et al. (2008) Influence of surgical margin on the type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 143:384-393.